tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Definium Therapeutics price target raised to $36 from $20 at RBC Capital
PremiumThe FlyDefinium Therapeutics price target raised to $36 from $20 at RBC Capital
7d ago
Psychedelic: Analyst initiates Atai Beckley with Buy rating
Premium
The Fly
Psychedelic: Analyst initiates Atai Beckley with Buy rating
8d ago
Definium Therapeutics Launches Educational LSD Campaign to Advance Psychedelic Psychiatry
Premium
Company Announcements
Definium Therapeutics Launches Educational LSD Campaign to Advance Psychedelic Psychiatry
10d ago
Definium Therapeutics: Advancing Late-Stage Psychedelic Pipeline and Diversifying Assets Underpin Buy Rating and $61 Target
PremiumRatingsDefinium Therapeutics: Advancing Late-Stage Psychedelic Pipeline and Diversifying Assets Underpin Buy Rating and $61 Target
10d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100